title: Influence of levetiracetame on ictal and postictal EEG in patients with partial seizures.
abstract: To investigate the influence of levetiracetame (LEV) treatment on the interhemispheric seizure pattern propagation and postictal recovery of electroencephalography (EEG) background activity. Twenty-three adult patients (age > 16 years) with pharmacoresistant focal epilepsies presenting at the Epilepsy Center Erlangen for pre-surgical evaluation were enrolled in the study. Those eligible patients receiving only one antiepileptic drugs were recruited to the 48-h baseline phase and, after at least two seizures, were randomized to the 7-day treatment phase with either LEV (n = 11) or placebo (n = 12). All participants were submitted to continuous day-and-night video-EEG monitoring. The daily dose of LEV was 1000 mg (500 mg bid.) on the first treatment day and was increased to 2000 mg (1000 mg bid.) from the second day onward. The EEG changes relating to the time delay of the interhemispheric seizure pattern propagation and to the postictal recovery of the background activity were analysed by computerized video-EEG recording and compared using the non-parameter Mann-Whitney U-exact test (alpha = 0.05). A prolonged latency of the contralateral seizure pattern propagation was observed in the LEV group, whereas a more rapid propagation was observed in the placebo group (P = 0.009). Postictal generalized slowing of the background activity was recorded in 21 patients during the baseline phase. More rapid postictal recovery of the EEG background activity was observed in the LEV, but not in the placebo group (P = 0.03). This study demonstrated that LEV not only prevented the seizure pattern propagation but also helped the speedy recovery of the postictal background activity in the EEG.
authors.affiliation: Department of Neurology, Epilepsy Center Erlangen, University of Erlangen-Nuremberg, 91054 Erlangen, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Tilz
authors.forename: H
authors.initials: H
authors.lastname: Stefan
authors.forename: R
authors.initials: R
authors.lastname: Hopfengaertner
authors.forename: F
authors.initials: F
authors.lastname: Kerling
authors.forename: A
authors.initials: A
authors.lastname: Genow
authors.forename: Y
authors.initials: Y
authors.lastname: Wang-Tilz
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D004311:Double-Blind Method; D004569:Electroencephalography / Q000379:methods; D020937:Epilepsy, Partial, Sensory / Q000188:drug therapy* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D000077287:Levetiracetam; D010889:Piracetam